Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
1287.8
Headquarter in Copenhagen and 16 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 4 EP applications Carsten Dietmar Prusko has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12734417

USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER

IPC classification:
A61K 38/16, A61P 37/04
Agent:
Carsten Dietmar Prusko, Zacco
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Anna-Louise Hally, F. R. Kelly & Co.
Status:
GRANT OF PATENT INTENDED
EP13817006

LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

IPC classification:
A61K 39/00, A61K 38/00, C12N 15/09, C12N 5/0783, C07K 16/44, C07K 14/47, A61P 35/00
Applicant:
OncoTherapy Science Inc
Agent:
Carsten Dietmar Prusko, Zacco
Status:
EXAMINATION IN PROGRESS
EP13817533

CDCA1 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

IPC classification:
A61K 39/00, A61K 38/00, C12N 15/09, C12N 5/0783, C07K 16/44, C07K 14/47, A61P 35/00
Applicant:
OncoTherapy Science Inc
Agent:
Carsten Dietmar Prusko, Zacco
Status:
EXAMINATION IN PROGRESS
EP13816244

KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

IPC classification:
A61K 39/00, A61K 38/00, C12N 15/09, C12N 5/0783, C07K 16/44, C07K 14/47, A61P 35/00
Applicant:
OncoTherapy Science Inc
Agent:
Carsten Dietmar Prusko, Zacco
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature